The Latest News

Stay up-to-date on the latest news, ongoing insights and event information plus access a detailed archive of past events and press releases from ITS including details on collaboration and partnerships with the world’s leading pharmaceutical companies to identify specific target classes and therapeutic indications.
August 24, 2020
Tentarix Biotherapeutics Launches with a $50 Million Series A Financing
Read More
November 5, 2019
Innovative Targeting Solutions and Former Amgen Executive Team up to Launch A2 Biotherapeutics with a $57 Million Series A
Read More
October 21, 2019
Innovative Targeting Solutions Inc. announces the issuance of two European patents applying the HuTARG™ platform to targeted mutagenesis and the engineering of functional agonists to GPCRs
Read More